129 related articles for article (PubMed ID: 9679735)
1. Expression of two type II-like tumor hexokinase RNA transcripts in cancer cell lines.
Sebastian S; Kenkare UW
Tumour Biol; 1998; 19(4):253-60. PubMed ID: 9679735
[TBL] [Abstract][Full Text] [Related]
2. High Km glucose-phosphorylating (glucokinase) activities in a range of tumor cell lines and inhibition of rates of tumor growth by the specific enzyme inhibitor mannoheptulose.
Board M; Colquhoun A; Newsholme EA
Cancer Res; 1995 Aug; 55(15):3278-85. PubMed ID: 7614462
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor I induces tumor hexokinase RNA expression in cancer cells.
Sebastian S; Kenkare UW
Biochem Biophys Res Commun; 1997 Jun; 235(2):389-93. PubMed ID: 9199203
[TBL] [Abstract][Full Text] [Related]
4. Quantitative determinations of the steady state transcript levels of hexokinase isozymes and glucose transporter isoforms in normal rat tissues and the malignant tumor cell line AH130.
Shinohara Y; Yamamoto K; Inoo K; Yamazaki N; Terada H
Biochim Biophys Acta; 1998 Jan; 1368(1):129-36. PubMed ID: 9459591
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of hexokinase I in pancreatic islets induced by sucrose administration.
Maiztegui B; Borelli MI; Massa ML; Del Zotto H; Gagliardino JJ
J Endocrinol; 2006 May; 189(2):311-7. PubMed ID: 16648298
[TBL] [Abstract][Full Text] [Related]
6. Developmental expression of glucokinase in rat hypothalamus.
Sutherland VL; McReynolds M; Tompkins LS; Brooks HL; Lynch RM
Brain Res Dev Brain Res; 2005 Feb; 154(2):255-8. PubMed ID: 15707679
[TBL] [Abstract][Full Text] [Related]
7. Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase.
Gomis RR; Cid E; García-Rocha M; Ferrer JC; Guinovart JJ
J Biol Chem; 2002 Jun; 277(26):23246-52. PubMed ID: 11882651
[TBL] [Abstract][Full Text] [Related]
8. Glucokinase and hexokinase expression and activities in rainbow trout tissues: changes with food deprivation and refeeding.
Soengas JL; Polakof S; Chen X; Sangiao-Alvarellos S; Moon TW
Am J Physiol Regul Integr Comp Physiol; 2006 Sep; 291(3):R810-21. PubMed ID: 16614057
[TBL] [Abstract][Full Text] [Related]
9. Hexokinase isoenzymes in the rat placenta.
Boileau P; Caüzac M; Girard J; Hauguel-de Mouzon S
Placenta; 1998; 19(5-6):439-42. PubMed ID: 9699967
[TBL] [Abstract][Full Text] [Related]
10. [Identification and characterization of hexokinase isozyme predominantly expressed in malignant tumor cells].
Shinohara Y
Yakugaku Zasshi; 2000 Aug; 120(8):657-66. PubMed ID: 10946615
[TBL] [Abstract][Full Text] [Related]
11. [Some characteristics of isoenzymic spectrum of hexokinase and glucose levels in hepatomas and liver of the host].
Shapot VS; Gorozhanskaia EG; Liubimova NA
Biokhimiia; 1976 Oct; 41(10):1766-72. PubMed ID: 192329
[TBL] [Abstract][Full Text] [Related]
12. Exhibition of specific alterations in activities and mRNA levels of rat islet glycolytic and mitochondrial enzymes in three different in vitro model systems for attenuated insulin release.
Svensson C; Welsh N; Krawetz SA; Welsh M
Diabetes; 1991 Jun; 40(6):771-6. PubMed ID: 1645683
[TBL] [Abstract][Full Text] [Related]
13. Hexokinase type II: a novel tumor-specific promoter for gene-targeted therapy differentially expressed and regulated in human cancer cells.
Katabi MM; Chan HL; Karp SE; Batist G
Hum Gene Ther; 1999 Jan; 10(2):155-64. PubMed ID: 10022541
[TBL] [Abstract][Full Text] [Related]
14. Control of glucose metabolism in pancreatic beta-cells by glucokinase, hexokinase, and phosphofructokinase. Model study with cell lines derived from beta-cells.
Shimizu T; Parker JC; Najafi H; Matschinsky FM
Diabetes; 1988 Nov; 37(11):1524-30. PubMed ID: 2972577
[TBL] [Abstract][Full Text] [Related]
15. Determining and understanding the control of glycolysis in fast-growth tumor cells. Flux control by an over-expressed but strongly product-inhibited hexokinase.
Marín-Hernández A; Rodríguez-Enríquez S; Vital-González PA; Flores-Rodríguez FL; Macías-Silva M; Sosa-Garrocho M; Moreno-Sánchez R
FEBS J; 2006 May; 273(9):1975-88. PubMed ID: 16640561
[TBL] [Abstract][Full Text] [Related]
16. Modeling cancer glycolysis under hypoglycemia, and the role played by the differential expression of glycolytic isoforms.
Marín-Hernández A; López-Ramírez SY; Del Mazo-Monsalvo I; Gallardo-Pérez JC; Rodríguez-Enríquez S; Moreno-Sánchez R; Saavedra E
FEBS J; 2014 Aug; 281(15):3325-45. PubMed ID: 24912776
[TBL] [Abstract][Full Text] [Related]
17. Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency.
Magnani M; Chiarantini L; Stocchi V; Dachà M; Fornaini G
J Inherit Metab Dis; 1986; 9(2):129-39. PubMed ID: 3091919
[TBL] [Abstract][Full Text] [Related]
18. Mammalian hexokinases and their abnormal expression in cancer.
Smith TA
Br J Biomed Sci; 2000; 57(2):170-8. PubMed ID: 10912295
[TBL] [Abstract][Full Text] [Related]
19. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function.
Wilson JE
J Exp Biol; 2003 Jun; 206(Pt 12):2049-57. PubMed ID: 12756287
[TBL] [Abstract][Full Text] [Related]
20. Regulation of glucose transporter and hexokinase II expression in tissues of diabetic rats.
Burcelin R; Printz RL; Kande J; Assan R; Granner DK; Girard J
Am J Physiol; 1993 Sep; 265(3 Pt 1):E392-401. PubMed ID: 8214048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
